Weight-loss drug linked to hair loss risk, BMJ study finds

The findings come from research published directly in The BMJ, which the journal shared on its official account. The study looked at adults with type 2 diabetes taking GLP-1 receptor agonist (GLP-1 RA) drugs — medicines that mimic a gut hormone to control blood sugar and suppress appetite — and found a link with alopecia (hair loss) compared with people not taking the drugs.

Alopecia is the medical term for hair loss, which can range from thinning at the scalp to more noticeable patches. The BMJ study does not describe the hair loss as severe or permanent, and the journal’s own summary of the findings stresses that the absolute risk is low.

GLP-1 drugs have become some of the most talked-about medicines in the UK over the past few years, prescribed both for type 2 diabetes management and, increasingly, for weight loss. That wider use makes awareness of possible side effects more relevant for patients and the clinicians advising them.

So what does this mean in practice? The BMJ framed the findings as information to support shared decision-making between patients and their doctors — not as a reason to stop or avoid treatment.

Anyone already taking a GLP-1 drug who is concerned about hair loss should speak to their GP rather than stopping medication without advice. GPs can weigh up the benefits of the treatment against any side effects a patient is experiencing and discuss whether any changes are needed.

Key information

• Speak to your GP if you are taking a GLP-1 drug and have noticed unexpected hair loss
• Do not stop prescribed medication without first getting advice from your GP or diabetes care team
• NHS 111 is available by phone or online if you need health guidance outside of GP hours
• Diabetes UK helpline: 0345 123 2399 for support and information about diabetes treatments